Trials / Active Not Recruiting
Active Not RecruitingNCT06714448
A Study of the Effectiveness of Risk Minimization Measures Related to Depakine® (Sodium Valproate) in Saudi Arabia
Post Authorization Safety Study Assessing the Effectiveness of Risk Minimization Measures Related to Depakine® (Sodium Valproate) in Saudi Arabia
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,500 (estimated)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
A cross-sectional, national, multicenter, survey-based study to assess the effectiveness of Risk Minimization Measures related to Depakine® (sodium valproate) in Saudi Arabia. The end of study is defined as the end of the data collection period. No intervention will be administered, and no study related visits are required.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sodium valporate | This study will not administer any treatment, only observe the treatment as prescribed in real-world clinical practices. |
Timeline
- Start date
- 2025-04-29
- Primary completion
- 2026-03-31
- Completion
- 2026-03-31
- First posted
- 2024-12-03
- Last updated
- 2026-03-09
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06714448. Inclusion in this directory is not an endorsement.